Date: Tuesday, July 26, 2016
Time: 12:30pm – 1:30pm
Location: Street Level Conference Room
Showing 1 to 1 of 1 items tagged as biologics
Descriptions: "CBER is the Center within FDA that regulates biological products for human use under applicable federal laws, including the Public Health Service Act and the Federal Food, Drug and Cosmetic Act." CBER reports on the availability, recall and approval of such products, like recombinant DNA proteins, blood, vaccine and tissue. As the regulator, CBER provides legal and best practices information for the biologics it oversees, including xenotransplantation. Guidance is provided here for consumers, health professionals and the biologics industry itself. Interested users can sign up for RSS feeds, podcasts and a mailing list.
Keywords: biologics, blood, DNA, hematology, law, medicine, regulations, research, U.S. Government, vaccine